Form 6-K RedHill Biopharma Ltd. For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Redhill Biopharma (RDHL) PT Raised to $28 at Nomura/Instinet
July 30, 2018 1:00 PM EDTNomura/Instinet raised its price target on Redhill Biopharma (NASDAQ: RDHL) to $28.00 (from $18.00) while maintaining a Buy rating following positive RHB-104 results.
Analyst Christopher Marai note management indicated that a 16-week time-point measure is a reasonable endpoint, but they will await... More
